T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 05/31/2016
Domestic Stock 57.3%
Domestic Bond 20.2%
Cash 15.6%
Foreign Bonds 4.4%
Foreign Stock 2.2%
Convertibles 1.0%
Preferreds 0.9%
Options -0.4%
Volatility and Other Measures
as of 05/31/2016
Beta 0.64
0.94
Standard Deviation 7.35
Price/Earnings Ratio (Domestic) 19.0
Earnings Growth Rate (Domestic) 11.3
Turnover Rate 21.8
Median Market
Capitalization
$45,302.1 Million
Sector Diversification
as of 05/31/2016
% of Total Net Assets
Health Care 15.8%
Financials 13.1%
Industrials & Business Services 9.3%
Information Technology 8.9%
Consumer Discretionary 7.0%
Consumer Staples 3.7%
Utilities 1.5%
Energy 0.6%
Telecommunication Services 0.6%
Materials 0.0%
10 Largest Holdings
Represents 26.52 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
Bank of New York Mellon
Becton, Dickinson & Company
Danaher
Marsh & McLennan
Microsoft
Pfizer
Thermo Fisher Scientific
Tyco International
Willis Group Holdings
As of 05/31/2016 the Capital Appreciation Fund had a total of 269 holdings.
See Glossary for additional details on all data elements.